Meadow Creek Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $226K | Sell |
3,231
-161
| -5% | -$11.3K | 0.15% | 129 |
|
2025
Q1 | $249K | Buy |
3,392
+10
| +0.3% | +$735 | 0.19% | 115 |
|
2024
Q4 | $222K | Buy |
3,382
+40
| +1% | +$2.62K | 0.16% | 125 |
|
2024
Q3 | $260K | Sell |
3,342
-1
| -0% | -$78 | 0.21% | 109 |
|
2024
Q2 | $261K | Buy |
3,343
+38
| +1% | +$2.96K | 0.25% | 97 |
|
2024
Q1 | $224K | Buy |
3,305
+190
| +6% | +$12.9K | 0.16% | 124 |
|
2023
Q4 | $210K | Buy |
+3,115
| New | +$210K | 0.2% | 98 |
|
2019
Q4 | $252K | Buy |
+5,046
| New | +$252K | 0.35% | 81 |
|